Novo Nordisk India launches oral formulation to treat diabetes

January 20, 2022

Semaglutide, a GLP-1 receptor analogue (GLP-1 RA), is indicated for the management of type 2 diabetes.

Read more at www.biospectrumindia.com

Tags

January 20, 2022

Read Next

May 27, 2022

Experiencing diabetes-related pain or numbness? Here's how one doctor says some relief …

May 26, 2022

Lean diabetes: reality that needs further research, says study – The Hindu

May 26, 2022

Epigenetic markers associated with different risks of developing complications in type 2 diabetes

May 18, 2022

Gestational diabetes mellitus in overweight and obese pregnant women may increase …

May 13, 2022

Worldwide study of diverse populations sheds new light on how genes contribute to type 2 diabetes